肝性脑病的预防与治疗进展

doi:10.3969/j.issn.1672-5069.2014.02.003

Abstract

Zhang Xuqing.. Advances in prevention and treatment of hepatic encephalopathy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 121-124.

[1] Beibel W，Al-Osaimi AM. Hepatic encephalopathy. Saudi J Gastroenterol，2012，18:301-309.
[2] Holeeek M. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives. Metab Brain Dis，2013，DOI 10.1007/s11011-013-9428-9.
[3] Tranah TH，Vijay GK，Ryan JM，et al. Systemic inflammation and ammonia in hepatic encephalopathy. Metab Brain Dis，2013，28:1-5.
[4] Reddy PV，Rama Rao KV，Norenberg MD. Inhibitors of the mitochondrial permeability transition reduce ammonia-induced cell swelling in cultured astrocytes. J Neurosci Res，2009，87:2677-2685.
[5] Cordoba J，Minguez B. Hepatic encephalopathy. Semin Liver Dis，2008，28:70-80.
[6] Amodio P，Bemeur C，Butterworth R，et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology，2013，58:325-336.
[7] de Melo RT，Charneski L，Hilas O. Rifaximin for the treatment of hepatic encephalopathy. Am J Health Syst Pharm，2008，65:818-822.
[8] Chacko KR，Sigal SH. Update on management of patients with overt hepatic encephalopathy. Hosp Pract，2013，41:48-59.
[9] Alvares-da-Silva1 MR，de Araujo A，Vicenzi1 JR，et al. Oral L-ornithine-L-aspartate in minimal hepatic encephalopathy:a randomized，double blind placebo-controlled trial. Hepatol Res，2013， doi:10.1111/ hepr.12235.
[10] Jiang Q，Jiang G，Welty TE，et al. Naloxone in the management of hepatic encephalopathy. J Clin Pharm Ther，2010，35:333-341.
[11] Jiang Q，Jiang G，Shi KQ，et al. Oral acetyl-L-carnitine treatment in hepatic encephalopathy:view of evidence-based medicine. Ann Hepatol，2013，12:803-809.
[12] Bajaj JS，Pinkerton SD，Sanyal AJ，et al. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents:a cost-effectiveness analysis. Hepatology，2012，55（4）:1164-1171.
[13] Dhiman RK，Saraswat VA，Sharma BK，et al. Minimal hepatic encephalopathy:consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol，2010，25（6）:1029-1041.
[14] Ampuero J，Ranchal I，Nu ez D，et al. Metformin inhibits glutaminase activity and protects against hepatic encephalopathy. PLoS One，2012，7（11）:e49279.
[15] Bajaj JS，Hafeezullah M，Franco J，et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology，2008，135（5）:1591-1600.
[16] Stephens S，Nyman H，Shane-McWhorter L. Assessing and treating hepatic encephalopathy in the older patient. Consult Pharm，2012，27（11）:797-802.
[17] Toris GT，Bikis CN，Tsourouflis GS，et al. Hepatic encephalopathy:an updated approach from pathogenesis to treatment. Med Sci Monit，2011，17（2）:RA53-63.
[18] Cudalbu C. In vivo studies of brain metabolism in animal models of hepatic encephalopathy using H magnetic resonance spectroscopy. Metab Brain Dis，2013，28（2）:167-174.
[19] Prakash RK，Kanna S，Mullen KD. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis. Clin Ther，2013，35（9）:1458-1473.
[20] Prakash R，Mullen KD. Mechanisms，diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol，2010，7（9）:515-525.
[21] Zhan T，Stremmel W. The diagnosis and treatment of minimal hepatic encephalopathy. Dtsch Arztebl Int，2012，109（10）:180-187.
[22] Montgomery JY，Bajaj JS. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep，2011，13（1）:26-33.

Advances in prevention and treatment of hepatic encephalopathy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[2]	Ren Hongwei, Gao Zhihua.. Connection changes between bilateral paleness and whole brain network in patients with hepatic encephalopathy by resting state fMRI scan [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 920-923.
[3]	Wang Jun, Zhang Liu, Xiong Huagang, et al. Efficacy of Xingnaojing,a herbal compound,combined with naloxone in treatment of patients with hepatitis B-induced liver cirrhosis complicated by hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 471-472.
[4]	Sun Xiao. Application of microecological agents and enteral nutrition in patients with hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 777-778.
[5]	Hua Xingping, Zhu Weigang, Liu Mingshui. A retrospective study of 60 hepatic encephalopathy induced by bacterial infection in patients with hepatitis B cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 358-359.
[6]	Chen Zhendao, Chen Hao.. Observation of the clinical efficacy of cerebrolysin combined with probiotics in treatment of patients with hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 583-586.
[7]	Chen Dongfeng, Sun Wenjing. New concept of hepatic encephalopathy:from guideline to clinical practice [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 16-19.
[8]	Hao Yanshuang, Ma Puhong, Cao Jianguo, et al. Risk factor of hepatic encephalopathy in patients with hepatitis B liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 90-91.
[9]	Chen Guangjian，Xie Bimei，Li Xiangxing，et al.. Factors influencing prognosis of patients with hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 548-549.
[10]	Zhang Min. Risk factors influencing prognosis of patients with hepatic encephalopathy complicating uncompensated liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 188-190.
[11]	Song Xiuli. Clinical efficacy of L-ornithine-L-aspartate combined with naloxone in treatment of patients with hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 82-83.
[12]	Chen Yuning, Wang Jinhui, Xue Lifeng. Clinical features of patients with Wilson's disease in different clinical classification [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(4): 392-396.
[13]	He Runlian, Yang Jinhui. Diagnosis of minimal hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(3): 325-329.
[14]	Sun Wenjin, Wang Lizhi, Wang Yundong. Intravenous administration of ornithine aspartate and retention enema of lactulose in treatment of patients with hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(1): 86-87.
[15]	PAN Qiaoling，LIU Xiaojing，CHEN Tianyan.. Correlation of the plasma levels of neurotensin and calcitonin gene-related peptide to the severity of hepatic encephalopathy in rats with acute liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(6): 404-406.